(CTMX) CytomX Therapeutics - Performance 92.3% in 12m
CTMX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-65.68%
#93 in Peer-Group
Rel. Strength
93.03%
#536 in Stock-Universe
Total Return 12m
92.31%
#16 in Peer-Group
Total Return 5y
-69.51%
#77 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 5.17 |
| P/E Forward | 7.51 |
| High / Low | USD |
|---|---|
| 52 Week High | 2.99 USD |
| 52 Week Low | 0.43 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 76.97 |
| Buy/Sell Signal +-5 | 1.05 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: CTMX (92.3%) vs XBI (-8.5%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.07% | 70.8% | 77.8% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.62% | -7.07% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.72% | -1.16% | 36% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.73% | 30.3% | -4.82% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.97% | -9.23% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
15% | 42% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-5.87% | 54.7% | -9.25% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
4.56% | 32% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: CTMX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CTMX
| Total Return (including Dividends) | CTMX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -5.30% | 1.17% | 4.68% |
| 3 Months | 479.37% | 16.79% | 24.35% |
| 12 Months | 92.31% | -8.54% | 14.02% |
| 5 Years | -69.51% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | CTMX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -53% | 4.4% | 81% |
| 3 Months | 84.1% | 78.8% | 96.9% |
| 12 Months | -18.1% | -85.8% | 44.9% |
| 5 Years | -83.3% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th44.00 | -6.40% | -9.54% |
| 3 Month | %th100.00 | 396.07% | 365.92% |
| 12 Month | %th93.00 | 110.27% | 68.66% |
| 5 Years | %th62.00 | -59.77% | -85.61% |
FAQs
Does CytomX Therapeutics (CTMX) outperform the market?
Yes,
over the last 12 months CTMX made 92.31%, while its related Sector, the SPDR S&P Biotech (XBI) made -8.54%.
Over the last 3 months CTMX made 479.37%, while XBI made 16.79%.
Performance Comparison CTMX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CTMX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 8.9% | -10% | 113.6% | 78% |
| US NASDAQ 100 | QQQ | 9.3% | -10.4% | 113% | 80% |
| German DAX 40 | DAX | 10.1% | -3.7% | 101.5% | 63% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 9.4% | -8.7% | 110.2% | 72% |
| Hongkong Hang Seng | HSI | 8.6% | -10.7% | 94.2% | 52% |
| India NIFTY 50 | INDA | 9.9% | -6.9% | 113.3% | 93% |
| Brasil Bovespa | EWZ | 8.5% | -13% | 88.6% | 82% |
CTMX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 10.6% | -9.7% | 109.5% | 67% |
| Consumer Discretionary | XLY | 8.3% | -9.8% | 121.3% | 74% |
| Consumer Staples | XLP | 8.6% | -6.6% | 112% | 83% |
| Energy | XLE | 7.5% | -10.5% | 117.8% | 92% |
| Financial | XLF | 8.6% | -9.4% | 108.7% | 62% |
| Health Care | XLV | 9.6% | -6.6% | 121% | 97% |
| Industrial | XLI | 8.8% | -8.7% | 105.8% | 67% |
| Materials | XLB | 6.1% | -9.9% | 109.1% | 87% |
| Real Estate | XLRE | 9.2% | -6% | 113.9% | 80% |
| Technology | XLK | 8.7% | -13.3% | 111.3% | 82% |
| Utilities | XLU | 9.9% | -6.8% | 110.4% | 70% |
| Aerospace & Defense | XAR | 11.1% | -10.7% | 95.1% | 44% |
| Biotech | XBI | 7.3% | -6.5% | 126.9% | 101% |
| Homebuilder | XHB | 6% | -13.3% | 120.8% | 88% |
| Retail | XRT | 5.5% | -8.5% | 118% | 81% |
CTMX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 7.3% | -10.6% | 122% | 99% |
| Natural Gas | UNG | 10.3% | 5.9% | 130.4% | 96% |
| Gold | GLD | 9.4% | -5.9% | 93% | 52% |
| Silver | SLV | 8% | -7.8% | 96.3% | 73% |
| Copper | CPER | 9.3% | -10.9% | 96.6% | 80% |
CTMX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 11.2% | -7.6% | 117.1% | 95% |
| iShares High Yield Corp. Bond | HYG | 10% | -7.1% | 114.7% | 82% |